Work

Abstract 2934: AKT mutant allele-specific activation dictates pharmacologic sensitivities

Year: 2019

Type: conference-abstract

Source: Experimental and Molecular Therapeutics

DOI: 10.1158/1538-7445.sabcs18-2934

Authors: Tripti Shrestha Bhattarai, Tambudzai Shamu, Swati Patel, Alexander Gorelick, Matthew T. Chang, Elena I. Gavrila, JianJong Gao, Mark T. Donoghue, Paul S. Gao, Tara Soumerai, Wassim Abida, Lilian M. Smyth, David M. Hyman, David B. Solit, Barry S. Taylor

Institutions: Memorial Sloan Kettering Cancer Center, Genentech

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4256207331

Cites:

Cited by:

Related to: 10